Panobinostat lactate
98%
- Product Code: 228325
CAS:
960055-56-5
| Molecular Weight: | 439.50 g./mol | Molecular Formula: | C₂₄H₂₉N₃O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in the treatment of multiple myeloma, particularly in patients who have received prior therapy including bortezomib and immunomodulatory drugs. It functions as a histone deacetylase (HDAC) inhibitor, helping to restore normal gene expression in cancer cells, leading to cell cycle arrest and apoptosis. Often administered in combination with other agents like bortezomib and dexamethasone to enhance efficacy. Its application is primarily in relapsed or refractory cases where other treatments have failed.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | ฿38,000.00 |
+
-
|
| 25mg | 10-20 days | ฿85,000.00 |
+
-
|
Panobinostat lactate
Used in the treatment of multiple myeloma, particularly in patients who have received prior therapy including bortezomib and immunomodulatory drugs. It functions as a histone deacetylase (HDAC) inhibitor, helping to restore normal gene expression in cancer cells, leading to cell cycle arrest and apoptosis. Often administered in combination with other agents like bortezomib and dexamethasone to enhance efficacy. Its application is primarily in relapsed or refractory cases where other treatments have failed.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :